Holen Sie sich die Stockscreener-App
2.25
2.74%
0.06
Handel nachbörslich:
2.25
Seastar Medical Holding Corp Aktie (ICU) Neueste Nachrichten
SeaStar Soars on Latest Tidings - Baystreet.ca
SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer - Yahoo Finance
SeaStar Medical reports net revenue of USD 67,500 in Q3 2024 - Medical Buyer
SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update - Yahoo Finance
Critical Analysis: Merit Medical Systems (NASDAQ:MMSI) and SeaStar Medical (NASDAQ:ICU) - Defense World
SeaStar Medical (NASDAQ:ICU) Trading Down 3% – Here’s What Happened - Defense World
FDA grants breakthrough status to SeaStar Medical's SCD - Investing.com
FDA Grants Breakthrough Device Designation for SeaStar - GlobeNewswire
FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis - Yahoo Finance
Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial - GlobeNewswire
SeaStar Medical Adds Second Hospital Customer for QUELIMMUNE - Yahoo Finance
ICUSeaStar Medical Holding Corporation Latest Stock News & Market Updates - StockTitan
Economic Analysis Supporting Significant Hospitalization Cost Reduction with SeaStar Medical’s QUELIMMUNE Pediatric Therapeutic Device Presented at ASN Kidney Week 2024Update - Yahoo Finance
SeaStar Medical Announces that Stanford Medicine is Cleared - GlobeNewswire
Seastar Medical settles dispute with Nuwellis for $900K - Investing.com
Seastar Medical settles dispute with Nuwellis for $900K By Investing.com - Investing.com UK
SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers - GlobeNewswire
SeaStar Medical's NEUTRALIZE-AKI trial surpasses halfway mark - Investing.com
SeaStar Medical's NEUTRALIZE-AKI trial surpasses halfway mark By Investing.com - Investing.com South Africa
SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis - GlobeNewswire
SeaStar Medical to Showcase New Mechanistic Data - GlobeNewswire
SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit - GlobeNewswire
SeaStar Medical expands trial sites for kidney injury device - Investing.com
SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities - GlobeNewswire
SeaStar medical executive buys $4.3k in company stock By Investing.com - Investing.com Australia
SeaStar medical executive buys $4.3k in company stock - Investing.com
SeaStar Medical Reports Enrollment Momentum in Its Pivotal Adult AKI Trial - GlobeNewswire
Seaport Entertainment Group Announces Commencement of Rights Offering - StockTitan
SEA (NYSE:SE) Shares Gap Up After Analyst Upgrade - Defense World
Sea Limited (NYSE:SE) Stake Decreased by HighVista Strategies LLC - Defense World
Sea Limited (NYSE:SE) Shares Sold by Itau Unibanco Holding S.A. - Defense World
Skandinaviska Enskilda Banken AB publ Has $4.09 Million Position in Sea Limited (NYSE:SE) - Defense World
SeaChange International (NASDAQ:SEAC) Coverage Initiated at StockNews.com - Defense World
Sea Limited (NYSE:SE) Shares Bought by Sei Investments Co. - Defense World
SEA (NYSE:SE) Hits New 1-Year High at $84.60 - Defense World
Why the Market Dipped But Sea Limited Sponsored ADR (SE) Gained Today - Yahoo Finance
SEA (NYSE:SE) Sets New 1-Year High at $84.60 - MarketBeat
Closing Bell Recap: Seelos Therapeutics Inc (SEEL) Ends at 0.20, Reflecting a -11.51 Downturn - The Dwinnex
Sea Limited stock soars to 52-week high of $85.16 By Investing.com - Investing.com Australia
Sea Limited stock soars to 52-week high of $85.16 - Investing.com
Parallel Advisors LLC Purchases 250 Shares of Sea Limited (NYSE:SE) - Defense World
Sea Limited (NYSE:SE) Receives $80.00 Average Target Price from Analysts - MarketBeat
Sea Limited (NYSE:SE) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Daiwa Securities Group Inc. Boosts Stake in Sea Limited (NYSE:SE) - Defense World
Ballentine Partners LLC Acquires Shares of 2,962 Sea Limited (NYSE:SE) - Defense World
Rhumbline Advisers Cuts Position in Sea Limited (NYSE:SE) - Defense World
SeaStar Medical (NASDAQ:ICU) Shares Up 5.5% - Defense World
FINAL ICU DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Seastar Medical Holding Corp. Investors to Join the Class Action Lawsuit! - AccessWire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against SeaStar Medical Holding Corporation (ICU) - Business Wire
ICU Deadline: Rosen Law Firm Urges SeaStar Medical Holding Corporation (ICU, ICUCW) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - The Bakersfield Californian
SeaStar Medical to Webcast Fireside Chat at the H.C. Wainwright Global Investment Conference - GlobeNewswire
SeaStar Medical Holding Corporation retires all long-term debt - Medical Buyer
2024-09-05 | Lost Money on SeaStar Medical Holding Corporation (ICU)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky | NDAQ:ICU | Press Release - Stockhouse Publishing
2024-09-04 | Investors in SeaStar Medical Holding Corporation Should Contact Levi & Korsinsky Before September 6, 2024 to Discuss Your RightsICU | NDAQ:ICU | Press Release - Stockhouse Publishing
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SeaStar - Stockhouse Publishing
SeaStar Medical eliminates all long-term debt - Investing.com
SeaStar Medical Strengthens Financial Position with Elimination of All Long-Term Debt - GlobeNewswire
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):